4 years ago

Optimising combination of vascular endothelial growth factor and mesenchymal stem cells on ectopic bone formation in SCID mice

Søren Overgaard, Chris H. Dreyer, Kristian Kjærgaard, Ming Ding, Nicholas Ditzel, Niklas R. Jørgensen
Introduction: Insufficient blood supply may limit bone regeneration in bone defects. Vascular endothelial growth factor (VEGF) promotes angiogenesis by increasing endothelial migration. This outcome, however, could depend on time of application. Sheep mesenchymal stem cells (MSCs) in severe combined immunodeficient (SCID) mice were used in this study to evaluate optimal time points for VEGF stimulation to increase bone formation. Methods: Twenty-eight SCID (NOD.CB17-Prkdcscid/J) mice had hydroxyapatite (HA) granules seeded with 5x105 MSCs inserted subcutaneously. Pellets released VEGF on Days 1-7, Days 1-14, Days 1-21, Days 1-42, Days 7-14, and Days 21-42. After 8 weeks, the implant-bone-blocks were harvested, paraffin embedded, sectioned, and stained with both Haematoxylin Eosin (HE) and immunohistochemistry for human vimentin staining (hVim). Blood samples were collected for determination of bone-related biomarkers in serum. Results: The groups with 5x105 mesenchymal stem cells and VEGF stimulation on Days 1-14 and Days 1-21 showed more bone formation when compared to the control group of 5x105 mesenchymal stem cells alone (p<0.01). Serum biomarkers had no significant values. The hVim staining confirmed the ovine origin of the observed ectopic bone formation. Conclusion: Optimal bone formation of MSCs was reached when stimulating with VEGF during the first 14 or 21 days after surgery. This article is protected by copyright. All rights reserved.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/jbm.a.36195

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.